Development of a high-throughput platform to measure plasmid transfer frequency

Front Cell Infect Microbiol. 2023 Oct 11:13:1269732. doi: 10.3389/fcimb.2023.1269732. eCollection 2023.

Abstract

Antibiotic resistance represents one of the greatest threats to global health. The spread of antibiotic resistance genes among bacteria occurs mostly through horizontal gene transfer via conjugation mediated by plasmids. This process implies a direct contact between a donor and a recipient bacterium which acquires the antibiotic resistance genes encoded by the plasmid and, concomitantly, the capacity to transfer the acquired plasmid to a new recipient. Classical assays for the measurement of plasmid transfer frequency (i.e., conjugation frequency) are often characterized by a high variability and, hence, they require many biological and technical replicates to reduce such variability and the accompanying uncertainty. In addition, classical conjugation assays are commonly tedious and time-consuming because they typically involve counting colonies on a large number of plates for the quantification of donors, recipients, and transconjugants (i.e., the bacteria that have received the genetic material by conjugation). Due to the magnitude of the antibiotic resistance problem, it is critical to develop reliable and rapid methods for the quantification of plasmid transfer frequency that allow the simultaneous analysis of many samples. Here, we present the development of a high-throughput, reliable, quick, easy, and cost-effective method to simultaneously accomplish and measure multiple conjugation events in 96-well plates, in which the quantification of donors, recipients, and transconjugants is estimated from the time required to reach a specific threshold value (OD600 value) in the bacterial growth curves. Our method successfully discriminates different plasmid transfer frequencies, yielding results that are equivalent to those obtained by a classical conjugation assay.

Keywords: Escherichia coli; antibiotic resistance; bacterial conjugation; conjugation frequency; conjugation inhibitors; high-throughput screening platform; horizontal gene transfer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents* / pharmacology
  • Conjugation, Genetic*
  • Drug Resistance, Microbial
  • Gene Transfer, Horizontal
  • Plasmids / genetics

Substances

  • Anti-Bacterial Agents

Grants and funding

The authors declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by MCIN/AEI/10.13039/501100011033 (PID2020-116495RB-I00) and the Basque Government (IT1578-22). AR-S received an UPV/EHU Training of pre-doctoral Research Staff Grant. NS-F received an Ikasiker grant from the Basque Government.